These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 22462635)

  • 1. The effect of bone marrow microenvironment on the functional properties of the therapeutic bone marrow-derived cells in patients with acute myocardial infarction.
    Miettinen JA; Salonen RJ; Ylitalo K; Niemelä M; Kervinen K; Säily M; Koistinen P; Savolainen ER; Mäkikallio TH; Huikuri HV; Lehenkari P
    J Transl Med; 2012 Apr; 10():66. PubMed ID: 22462635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone marrow characteristics associated with changes in infarct size after STEMI: a biorepository evaluation from the CCTRN TIME trial.
    Schutt RC; Trachtenberg BH; Cooke JP; Traverse JH; Henry TD; Pepine CJ; Willerson JT; Perin EC; Ellis SG; Zhao DX; Bhatnagar A; Johnstone BH; Lai D; Resende M; Ebert RF; Wu JC; Sayre SL; Orozco A; Zierold C; Simari RD; Moyé L; Cogle CR; Taylor DA;
    Circ Res; 2015 Jan; 116(1):99-107. PubMed ID: 25406300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone marrow mesenchymal stem cells transfer in patients with ST-segment elevation myocardial infarction: single-blind, multicenter, randomized controlled trial.
    Zhang R; Yu J; Zhang N; Li W; Wang J; Cai G; Chen Y; Yang Y; Liu Z
    Stem Cell Res Ther; 2021 Jan; 12(1):33. PubMed ID: 33413636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of intracoronary hypoxia-preconditioned bone marrow mononuclear cell administration for acute myocardial infarction patients: The CHINA-AMI randomized controlled trial.
    Hu X; Huang X; Yang Q; Wang L; Sun J; Zhan H; Lin J; Pu Z; Jiang J; Sun Y; Xiang M; Liu X; Xie X; Yu X; Chen Z; Tse HF; Zhang J; Wang J
    Int J Cardiol; 2015 Apr; 184():446-451. PubMed ID: 25755063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved functional activity of bone marrow derived circulating progenitor cells after intra coronary freshly isolated bone marrow cells transplantation in patients with ischemic heart disease.
    Turan RG; Bozdag-T I; Ortak J; Kische S; Akin I; Schneider H; Turan CH; Rehders TC; Rauchhaus M; Kleinfeldt T; Belu C; Brehm M; Yokus S; Steiner S; Sahin K; Nienaber CA; Ince H
    Stem Cell Rev Rep; 2011 Sep; 7(3):646-56. PubMed ID: 21188654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intra-coronary bone marrow mononuclear cell transplantation in patients with ST-elevation myocardial infarction: a randomized controlled study.
    Srimahachota S; Boonyaratavej S; Rerkpattanapipat P; Wangsupachart S; Tumkosit M; Bunworasate U; Nakorn TN; Intragumtornchai T; Kupatawintu P; Pongam S; Saengsiri AO; Pothisri M; Sukseri Y; Bunprasert T; Suithichaiyakul T
    J Med Assoc Thai; 2011 Jun; 94(6):657-63. PubMed ID: 21696072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone Marrow Mononuclear Cells Transfer for Patients after ST-Elevated Myocardial Infarction: A Meta-Analysis of Randomized Control Trials.
    Zhang J; Lin L; Zong W
    Yonsei Med J; 2018 Jul; 59(5):611-623. PubMed ID: 29869459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracoronary autologous bone marrow cell transfer after myocardial infarction: the BOOST-2 randomised placebo-controlled clinical trial.
    Wollert KC; Meyer GP; Müller-Ehmsen J; Tschöpe C; Bonarjee V; Larsen AI; May AE; Empen K; Chorianopoulos E; Tebbe U; Waltenberger J; Mahrholdt H; Ritter B; Pirr J; Fischer D; Korf-Klingebiel M; Arseniev L; Heuft HG; Brinchmann JE; Messinger D; Hertenstein B; Ganser A; Katus HA; Felix SB; Gawaz MP; Dickstein K; Schultheiss HP; Ladage D; Greulich S; Bauersachs J
    Eur Heart J; 2017 Oct; 38(39):2936-2943. PubMed ID: 28431003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants of functional recovery after myocardial infarction of patients treated with bone marrow-derived stem cells after thrombolytic therapy.
    Miettinen JA; Ylitalo K; Hedberg P; Jokelainen J; Kervinen K; Niemelä M; Säily M; Koistinen P; Savolainen ER; Ukkonen H; Pietilä M; Airaksinen KE; Knuuti J; Vuolteenaho O; Mäkikallio TH; Huikuri HV
    Heart; 2010 Mar; 96(5):362-7. PubMed ID: 19910293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone-marrow-derived cell transfer after ST-elevation myocardial infarction: lessons from the BOOST trial.
    Drexler H; Meyer GP; Wollert KC
    Nat Clin Pract Cardiovasc Med; 2006 Mar; 3 Suppl 1():S65-8. PubMed ID: 16501634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of intracoronary injections of bone-marrow-derived mononuclear cells on large myocardial infarction outcome: quantum of initial necrosis is the key.
    Obradović S; Balint B; Romanovic R; Trifunović Z; Rusović S; Baskot B; Dopudja M; Trifunović G; Rafajlovski S; Jung R; Gligić B
    Vojnosanit Pregl; 2009 Dec; 66(12):998-1004. PubMed ID: 20095521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracoronary autologous mononucleated bone marrow cell infusion for acute myocardial infarction: results of the randomized multicenter BONAMI trial.
    Roncalli J; Mouquet F; Piot C; Trochu JN; Le Corvoisier P; Neuder Y; Le Tourneau T; Agostini D; Gaxotte V; Sportouch C; Galinier M; Crochet D; Teiger E; Richard MJ; Polge AS; Beregi JP; Manrique A; Carrie D; Susen S; Klein B; Parini A; Lamirault G; Croisille P; Rouard H; Bourin P; Nguyen JM; Delasalle B; Vanzetto G; Van Belle E; Lemarchand P
    Eur Heart J; 2011 Jul; 32(14):1748-57. PubMed ID: 21127322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracoronary bone marrow cell transfer after myocardial infarction: 5-year follow-up from the randomized-controlled BOOST trial.
    Meyer GP; Wollert KC; Lotz J; Pirr J; Rager U; Lippolt P; Hahn A; Fichtner S; Schaefer A; Arseniev L; Ganser A; Drexler H
    Eur Heart J; 2009 Dec; 30(24):2978-84. PubMed ID: 19773226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of intracoronary injection of autologous bone marrow-derived stem cells on natriuretic peptides and inflammatory markers in patients with acute ST-elevation myocardial infarction.
    Miettinen JA; Ylitalo K; Hedberg P; Kervinen K; Niemelä M; Säily M; Koistinen P; Savolainen ER; Ukkonen H; Pietilä M; Airaksinen KE; Knuuti J; Vuolteenaho O; Mäkikallio TH; Huikuri HV
    Clin Res Cardiol; 2011 Apr; 100(4):317-25. PubMed ID: 20953959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LateTIME: a phase-II, randomized, double-blinded, placebo-controlled, pilot trial evaluating the safety and effect of administration of bone marrow mononuclear cells 2 to 3 weeks after acute myocardial infarction.
    Traverse JH; Henry TD; Vaughan DE; Ellis SG; Pepine CJ; Willerson JT; Zhao DX; Simpson LM; Penn MS; Byrne BJ; Perin EC; Gee AP; Hatzopoulos AK; McKenna DH; Forder JR; Taylor DA; Cogle CR; Baraniuk S; Olson RE; Jorgenson BC; Sayre SL; Vojvodic RW; Gordon DJ; Skarlatos SI; Moyè LA; Simari RD;
    Tex Heart Inst J; 2010; 37(4):412-20. PubMed ID: 20844613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenosine stress perfusion cardiac magnetic resonance imaging in patients undergoing intracoronary bone marrow cell transfer after ST-elevation myocardial infarction: the BOOST-2 perfusion substudy.
    Seitz A; Wollert KC; Meyer GP; Müller-Ehmsen J; Tschöpe C; May AE; Empen K; Chorianopoulos E; Ritter B; Pirr J; Arseniev L; Heuft HG; Ganser A; Abu-Zaid E; Katus HA; Felix SB; Gawaz MP; Schultheiss HP; Ladage D; Bauersachs J; Mahrholdt H; Greulich S
    Clin Res Cardiol; 2020 May; 109(5):539-548. PubMed ID: 31401672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is the measurement of left ventricular ejection fraction the proper end point for cell therapy trials? An analysis of the effect of bone marrow mononuclear stem cell administration on left ventricular ejection fraction after ST-segment elevation myocardial infarction when evaluated by cardiac magnetic resonance imaging.
    Traverse JH; Henry TD; Moye' LA
    Am Heart J; 2011 Oct; 162(4):671-7. PubMed ID: 21982659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of timing on intracoronary autologous bone marrow-derived cell transplantation in acute myocardial infarction: a meta-analysis of randomized controlled trials.
    Xu JY; Liu D; Zhong Y; Huang RC
    Stem Cell Res Ther; 2017 Oct; 8(1):231. PubMed ID: 29037256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Timing for intracoronary administration of bone marrow mononuclear cells after acute ST-elevation myocardial infarction: a pilot study.
    Huang R; Yao K; Sun A; Qian J; Ge L; Zhang Y; Niu Y; Wang K; Zou Y; Ge J
    Stem Cell Res Ther; 2015 May; 6(1):112. PubMed ID: 26021558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial.
    Traverse JH; Henry TD; Pepine CJ; Willerson JT; Zhao DX; Ellis SG; Forder JR; Anderson RD; Hatzopoulos AK; Penn MS; Perin EC; Chambers J; Baran KW; Raveendran G; Lambert C; Lerman A; Simon DI; Vaughan DE; Lai D; Gee AP; Taylor DA; Cogle CR; Thomas JD; Olson RE; Bowman S; Francescon J; Geither C; Handberg E; Kappenman C; Westbrook L; Piller LB; Simpson LM; Baraniuk S; Loghin C; Aguilar D; Richman S; Zierold C; Spoon DB; Bettencourt J; Sayre SL; Vojvodic RW; Skarlatos SI; Gordon DJ; Ebert RF; Kwak M; Moyé LA; Simari RD;
    JAMA; 2012 Dec; 308(22):2380-9. PubMed ID: 23129008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.